Skip to Main Content

Paper Details

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
122
2021
CoV, CoV RBD, HexaPro, RBD, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike, mice, prefusion, sarbecovirus, sarbecovirus RBDs
Author NameAffiliation
Alexandra C WallsUniversity of Washington
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Prabhu S ArunachalamInstitute for Immunity, Stanford University School of Medicine, Stanford University
Mary Jane NavarroUniversity of Washington
Kenneth A RogersNew Iberia Research Center and Department of Biology, University of Louisiana at Lafayette
Ching-Lin HsiehThe University of Texas at Austin
Brooke FialaUniversity of Washington, USA Institute for Protein Design
Lauren CarterUniversity of Washington, USA Institute for Protein Design
Rino Rappuoli
Sarah R LeistUniversity of North Carolina at Chapel Hill
Derek T O'Hagan
Robbert G van der Most
Wesley C Van VoorhisUniversity of Washington School of Medicine
Jason S McLellanThe University of Texas at Austin
Harry KleanthousBill & Melinda Gates Foundation
Francois VillingerNew Iberia Research Center and Department of Biology, University of Louisiana at Lafayette
Bali PulendranInstitute for Immunity, Stanford University School of Medicine, Stanford University
Bali PulendranInstitute for Immunity, Stanford University School of Medicine, Stanford University
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Neil P KingUniversity of Washington, USA Institute for Protein Design
David VeeslerUniversity of Washington
  • 1 - 22

Datasets